Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.52 BRL | +0.24% | -4.99% | -33.89% |
Apr. 05 | Hospital Mater Dei S.A. announces an Equity Buyback for 9,613,168 shares, representing 2.51% of its issued share capital. | CI |
Apr. 04 | Hospital Mater Dei S.A. authorizes a Buyback Plan. | CI |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company appears to be poorly valued given its net asset value.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The company is in debt and has limited leeway for investment
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-33.89% | 409M | - | ||
-18.90% | 16.51B | B+ | ||
+4.50% | 12.53B | B | ||
+4.81% | 11.74B | B+ | ||
+2.43% | 10.06B | B+ | ||
+29.69% | 8.71B | B | ||
-4.75% | 7.57B | A- | ||
+19.68% | 7.22B | D | ||
+5.46% | 6.68B | B- | ||
-2.79% | 4.32B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MATD3 Stock
- Ratings Hospital Mater Dei S.A.